Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
Metabolic dysfunction-associated steatotic liver disease (MASLD) closely associates with obesity and type 2 diabetes. Lifestyle intervention and bariatric surgery aiming at substantial weight loss are cornerstones of MASLD treatment by improving histological outcomes and reducing risks of comorbidit...
Saved in:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2024
|
| 在线阅读: | https://doi.org/10.1016/j.metabol.2024.155937 |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|